B6;129S2-Esm1tm1.1Ics/Ics

Status

Available to order

EMMA IDEM:15812
Citation informationRRID:IMSR_EM:15812 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6;129S2-Esm1tm1.1Ics/Ics
Alternative nameEsm1tm1.1Ics
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolEsm1tm1.1Ics
Gene/Transgene symbolEsm1

Information from provider

ProviderPhilippe Lassalle
Provider affiliationInstitut Pasteur
Genetic informationThe knock-out of Esm1 was obtained by homologous recombination in 129/SvPas in-house derived ES cells (P1 ES cell line). Esm1 exon 1 (ENSMUSE00000404404) and exon 2 (ENSMUSE00000307442) were deleted and replaced by a floxed NeoR cassette. The NeoR cassette was excised by breeding the chimeras with cre recombinase deleter females. The cre transgene was segregated by breeding with C57BL/6N wild-type animals.
Phenotypic informationHomozygous:
Constitutive deletion of Esm1 in diabetic kidney disease (DKD)-resistant mice modestly increases the degree of diabetes-induced albuminuria versus wild-type controls. By glomerular RNAseq, Esm1 attenuates expression of kidney disease-promoting and interferon (IFN)-related genes, including Ackr2 and Cxcl11.

Heterozygous:
No data
Breeding historyES cells were 129/SvPas, chimeras were bred with cre deleter in a C57BL/6N genetic background. Current mixed background: 87.5% C57BL/6NTac, 6.25% C57BL/6J, 1.9% C57BL/6, 6.25% 129/SvPas.
References
  • Endothelial Cell-Specific Molecule-1 Inhibits Albuminuria in Diabetic Mice.;Zheng Xiaoyi, Higdon Lauren, Gaudet Alexandre, Shah Manav, Balistieri Angela, Li Catherine, Nadai Patricia, Palaniappan Latha, Yang Xiaoping, Santo Briana, Ginley Brandon, Wang Xiaoxin X, Myakala Komuraiah, Nallagatla Pratima, Levi Moshe, Sarder Pinaki, Rosenberg Avi, Maltzman Jonathan S, de Freitas Caires Nathalie, Bhalla Vivek, ;2022;Kidney360;3;2059-2076; 36591362
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreICS, Institut Clinique de la Souris, Illkirch-Graffenstaden, France

Literature references

  • Endothelial Cell-Specific Molecule-1 Inhibits Albuminuria in Diabetic Mice.;Zheng Xiaoyi, Higdon Lauren, Gaudet Alexandre, Shah Manav, Balistieri Angela, Li Catherine, Nadai Patricia, Palaniappan Latha, Yang Xiaoping, Santo Briana, Ginley Brandon, Wang Xiaoxin X, Myakala Komuraiah, Nallagatla Pratima, Levi Moshe, Sarder Pinaki, Rosenberg Avi, Maltzman Jonathan S, de Freitas Caires Nathalie, Bhalla Vivek, ;2022;Kidney360;3;2059-2076; 36591362

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).